Assessment of suitable antihypertensive therapies: Combination with high‐dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI‐AI study)

Author:

Nakagawa Naoki1ORCID,Sato Nobuyuki1,Saijo Yasuaki2,Morimoto Hideo3,Koyama Satoshi4,Ogawa Yuji5,Uekita Kazumi6,Maruyama Junichi4,Ohta Takafumi4,Nakamura Yasuhiro7,Takeuchi Toshiharu1,Hasebe Naoyuki1,

Affiliation:

1. Division of Cardiology, Nephrology, Pulmonology and Neurology Department of Internal Medicine Asahikawa Medical University Asahikawa Japan

2. Division of Community Medicine and Epidemiology Department of Health Science Asahikawa Medical University Asahikawa Japan

3. Department of Internal Medicine Fukagawa Municipal Hospital Fukagawa Japan

4. Department of Internal Medicine Asahikawa Rehabilitation Hospital Asahikawa Japan

5. Department of Cardiology Asahikawa Kosei General Hospital Asahikawa Japan

6. Department of Cardiology Hokkaido Kitami Hospital Kitami Japan

7. Department of Cardiology Municipal Ashibetsu Hospital Ashibetsu Japan

Funder

Waksman Foundation of Japan

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia

2. Management of morning hypertension: a consensus statement of an Asian expert panel

3. Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension

4. Asian management of hypertension: Current status, home blood pressure, and specific concerns in Japan

5. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Whelton PK;Hypertension,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3